Women Health Diagnostics Market Size, Share and Forecast 2019-2025
The global women health diagnostics market is significant growth at a CAGR 7.4% during the forecast period. The female bodysuffers from certain allergy, diseases, disorders, infections, anemia, and cancers such as autoimmune disease, renal disease, cardiovascular disease, and thyroid disease. There are number of cancer cases that are contributing to the increased use of gynecological surgical devices for the treatment of cancer and gynecological problems. The main types of cancer that commonly affect women’s health include cervical cancer, breast cancer, and ovarian cancer. In the female population, the breast cancer is the most common form of cancer occurring across the globe. The factors of breast cancer that propels the market growth include the slack of physical exercise, alcohol consumption, genetic history, menopausal changes, and exposure to ionizing radiations.
To Request a Sample of our Report on Women Health Diagnostics Market: https://www.omrglobal.com/request-sample/womens-health-diagnostics-market-size
There are various therapies, treatments, and medications that are used
to reduce the risk of cancer such as hormone therapy drugs that are enable to
treat breast cancer. Moreover, tamoxifen and raloxifene have been used for the
prevention of breast cancer. The hormone receptor (HR) positive breast cancers
are those that contain estrogen receptor (ER) and progesterone receptor (PR)
due to this cancer grow in response to these hormones and can be treated with
hormone therapies. The inhibitors also plays a prominent role in the breast
cancer such as aromatase inhibitors that consists exemestane and anastrozole.
Due to changing levels of ovarian hormones it makes less estrogen such
inhibitors have been used.
Breast tissue consist main components of ducts, fatty & fibrous connective tissue, and lobules. According to Cleveland Clinic Organization, the 5% of breast cancer cases occur in women under 40 years of age and diagnosing breast cancer in younger women is more difficult than older women, as the breast tissue are generally denser in young women than the breast tissues found in older women. According to the World Health Organization (WHO), breast cancer is the most frequent cancer that affects nearly 2.1 million women each year across the globe. In 2018, the mortality rate due to breast cancer reached to about 627,000; which covers nearly 15% of all cancer deaths among women.
According to Breast Cancer Organization, in January 2019, there are more than 3.1 million women suffers from the breast cancer in the US. The mortality rate of breast cancer is higher than any other cancer such as skin cancer, lung cancer, and prostate cancer. In 2019, it is estimated that about 30% of newly diagnosed cancers in women will be breast cancers. In 2019, the American Cancer Society estimates for breast cancer in the US for 2019 that about 268,600 new cases of invasive breast cancer will be diagnosed in women and about 41,760 women will lose their livesfrom breast cancer.
(Get 15% Discount on Buying this Report)
A
full Report of Women Health Diagnostics Market is Available at: https://www.omrglobal.com/industry-reports/womens-health-diagnostics-market-size
Global Women Health
Diagnostics Market- Segmentation
·
Breast
Cancer Testing
·
Cervical
Cancer Testing
·
Pregnancy
& Fertility Testing
·
Ovarian
Cancer Testing
·
Infectious
Disease Testing
·
Ultrasound
Tests
·
Sexually
Transmitted Disease Testing
·
Others
By End-User
·
Diagnostic
and Imaging Centers
·
Hospitals
and Clinics
·
Home
Care
Global Women
Health Diagnostics Market– Segment by Region
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of The World
·
Latin
America
·
Middle
East & Africa
Company
Profiles
·
Abbott
Laboratories, Inc.
·
Becton,
Dickson and Co.
·
biomerieux
SA
·
DIALAB
Gmbh
·
EKF
Diagnostics Holdings PLC
·
F.
Hoffmann-La Roche Ltd.
·
Fujifilm
Holdings Corp.
·
General
Electric Co.
·
GenMark
Diagnostics, Inc.
·
Hologic,
Inc.
·
Koninklijke
Philips N.V.
·
Luminex
Corp.
·
Nova
Biomedical Pte. Ltd.
·
PerkinElmer
Inc.
·
QIAGEN
N.V.
·
Quest
Diagnostics Inc.
·
Siemens
AG
·
Somagen
Diagnostics Inc.
·
Thermo
Fisher Scientific Inc.
·
Trinity
Biotech PLC
Reasons to Buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
For More Customized Data, Request for
Report Customization @ https://www.omrglobal.com/report-customization/womens-health-diagnostics-market-size
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an experienced
team of analysts and consultants. OMR offers quality syndicated research
reports, customized research reports, consulting and other research-based
services.
For
More Information, Visit Orion Market Research
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment